Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.4% during trading on Wednesday . The stock traded as high as $26.65 and ...

At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

The stock has lost 12% this year through Monday. Starboard Value's Chief Executive Jeff Smith has publicly accused Pfizer of squandering its Covid successes and has suggested that CEO Albert ...

Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.